SCHEMBL1505883

SCHEMBL1505883

COC(=O)c1ccc(Nc2ccc(C(=O)OC)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.64
KMT2A Q03164 5/20 0.64
CA1 P00915 2/20 0.64
CA2 P00918 2/20 0.64
TDP1 Q9NUW8 1/20 0.64
CA12 O43570 1/20 0.64
CA7 P43166 1/20 0.64
CA9 Q16790 1/20 0.64
CA14 Q9ULX7 1/20 0.64
HPGD P15428 3/20 0.62
KDM4E B2RXH2 2/20 0.62
RXFP1 Q9HBX9 1/20 0.62
MAPT P10636 4/20 0.60
ALDH1A1 P00352 3/20 0.60
TSHR P16473 1/20 0.60
SIRT2 Q8IXJ6 1/20 0.59
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
MAPK1 P28482 1/20 0.58
HTT P42858 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71303 0.92 TSHR (0.69) MEN1KMT2ACA1CA2HPGD
SCHEMBL5436969 0.90 CA1 (0.81) MEN1KMT2ACA1CA2TDP1
SCHEMBL28266243 0.90 DHODH (0.58) MEN1KMT2ACA1CA2TDP1
SCHEMBL5415723 0.90 MEN1 (0.74) MEN1KMT2ACA1CA2TDP1
SCHEMBL23999861 0.88 KMT2A (0.57) MEN1KMT2ACA1CA2TDP1
SCHEMBL14563219 0.88 MEN1 (0.62) MEN1KMT2ACA1CA2CA12
SCHEMBL28993944 0.87 CA1 (0.80) MEN1KMT2ACA1CA2TDP1
SCHEMBL23600 0.87 CA1 (0.80) MEN1KMT2ACA1CA2TDP1
SCHEMBL14563245 0.87 ALDH1A1 (0.62) MEN1KMT2ACA1CA2TDP1
SCHEMBL28266239 0.87 CDC25A (0.54) MEN1KMT2ACA1CA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276036-A1 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof JOHANNES GUTENBERG-UNIVERSITAT MAINZ (DE) 2007-11-29 US claimed
EP-1778625-A1 NON-GLYCOSIDIC AND NON-PEPTIDIC SELECT INHIBITORS, AND THE USE THEREOF Johannes Gutenberg-Universität Mainz (DE) 2007-05-02 EP claimed
WO-2006010598-A1 NON-GLYCOSIDIC AND NON-PEPTIDIC SELECT INHIBITORS, AND THE USE THEREOF Johannes Gutenberg-Universität Mainz (DE) 2006-02-02 WO claimed
EP-0623635-B1 Amine-functionalized polyester GEN ELECTRIC (US) 2003-02-19 EP claimed
US-5384387-A Amino acid or amino alcohol reacted into polymer GENERAL ELECTRIC COMPANY (US) 1995-01-24 US claimed
EP-0623635-A1 Amine-functionalized polyester GENERAL ELECTRIC COMPANY (US) 1994-11-09 EP claimed
US-7914908-B2 Organic electroluminescent device having an azatriphenylene derivative GLOBAL OLED TECHNOLOGY LLC (US) 2011-03-29 US disclosed
US-20090115316-A1 ORGANIC ELECTROLUMINESCENT DEVICE HAVING AN AZATRIPHENYLENE DERIVATIVE GLOBAL OLED TECHNOLOGY LLC 2009-05-07 US disclosed
US-7485742-B2 Non-glycosidic and non-peptidic inhibitors of selectin, and the use thereof Johannes Gutenberg-Universität Mainz (DE) 2009-02-03 US disclosed
US-20070276036-A1 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof JOHANNES GUTENBERG-UNIVERSITAT MAINZ (DE) 2007-11-29 US disclosed
US-7267892-B2 Electroluminescent devices having pendant naphthylanthracene-based polymers EASTMAN KODAK COMPANY (US) 2007-09-11 US disclosed
US-20070187673-A1 ELECTROLUMINESCENT DEVICES HAVING PENDANT NAPHTHYLANTHRACENE-BASED POLYMERS EASTMAN KODAK COMANY 2007-08-16 US disclosed
EP-1778625-A1 NON-GLYCOSIDIC AND NON-PEPTIDIC SELECT INHIBITORS, AND THE USE THEREOF Johannes Gutenberg-Universität Mainz (DE) 2007-05-02 EP disclosed
WO-2006010598-A1 NON-GLYCOSIDIC AND NON-PEPTIDIC SELECT INHIBITORS, AND THE USE THEREOF Johannes Gutenberg-Universität Mainz (DE) 2006-02-02 WO disclosed
EP-0623635-B1 Amine-functionalized polyester GEN ELECTRIC (US) 2003-02-19 EP disclosed
US-5519107-A MOLDING MATERIALS OF AROMATIC AMINE FUNCTIONAL POLYESTERS GENERAL ELECTRIC COMPANY (US) 1996-05-21 US disclosed
US-5384387-A Amino acid or amino alcohol reacted into polymer GENERAL ELECTRIC COMPANY (US) 1995-01-24 US disclosed
EP-0623635-A1 Amine-functionalized polyester GENERAL ELECTRIC COMPANY (US) 1994-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090115316-A1 ORGANIC ELECTROLUMINESCENT DEVICE HAVING AN AZATRIPHENYLENE DERIVATIVE DNMT1, EED, ALKBH2 MEN1 3373/4885KMT2A 386/4885CA1 4616/4885
US-20070276036-A1 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof VCAM1, ICAM1, SELPLG MEN1 2456/4885KMT2A 4616/4885CA1 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.